If approved, Tecentriq will be the first and only cancer immunotherapy available for certain people with early-stage NSCLC in Europe
This recommendation is based on new data from two randomized controlled trials involving 3078 patients
Within a fortnight, over 200 contestants sent their entries for the competition, and 30 names were shortlisted after screening entries under different categories
To meet the growing global demand for respiratory active pharmaceutical ingredients (APIs), Inke is to invest €9 million into its production plant to reinforce focus on inhalation micronised APIs
By strengthening the company's fibrotic disease development pipeline, Bridge will enhance its strategic focus on the development of comprehensive treatment solutions for idiopathic pulmonary fibrosis (IPF)
Through the association, Aster Volunteers would support 50 children from underprivileged families undergo liver transplants at Aster CMI and Aster RV Hospitals in Bangalore, and Aster Medcity and Aster MIMS Hospital Calicut in Kerala, India
The data driven fertility company helps increase the success rate of fertility treatments
The HD-550 endoscopy system has been available outside of the USA since 2019
Momelotinib complements GSK’s existing expertise in haematology, with Sierra Oncology anticipating US regulatory submission in Q2 this year and EU submission in the second half of 2022
This partnership allows both companies to become first movers to bridge an inevitable gap with the largest organizations in the pharmaceutical, nutraceutical, cosmetic, and veterinary sectors
Subscribe To Our Newsletter & Stay Updated
